DOCS.L LSE
Dr. Martens plc
1W: -1.8%
1M: -6.5%
3M: -8.6%
YTD: -3.1%
1Y: -27.0%
3Y: -55.6%
5Y: -81.9%
£66.60 ($0.88)
-0.50 (-0.75%)
Weekly Expected Move ±4.6%
£60
£64
£67
£70
£73
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$126M
-36.1% ▼
5Y CAGR: +0.7%
Capital Expenditures
$9M
+50.8% ▲
5Y CAGR: -15.9%
Free Cash Flow
$116M
-34.5% ▼
5Y CAGR: +3.2%
Dividends Paid
$25M
-158.9% ▼
Buybacks
$7M
+0.0% ▲
Net Change in Cash
$24M
-45.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $181M | $129M | $69M | $4M | $24M |
| Depreciation & Amort. | $37M | $54M | $72M | $72M | $69M |
| Stock-Based Comp. | $5M | $500K | $4M | $7M | $5M |
| Change in Working Capital | -$43M | -$146M | -$16M | $84M | $20M |
| Other Non-Cash Items | $15M | $17M | $39M | $28M | $8M |
| Operating Cash Flow | $184M | $77M | $168M | $196M | $126M |
| — Investing Activities — | |||||
| Capital Expenditures | -$25M | -$51M | -$18M | -$8M | -$12M |
| Acquisitions (Net) | $0 | -$1M | $0 | $0 | $0 |
| Investment Purchases | $0 | -$1M | $0 | $0 | $0 |
| Investment Sales | $0 | $13M | $0 | $0 | $0 |
| Other Investing | -$10M | -$10M | -$7M | -$7M | $0 |
| Investing Cash Flow | -$25M | -$51M | -$26M | -$15M | -$12M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | -$33M | $0 |
| Stock Repurchased | $0 | $0 | -$50M | $0 | -$7M |
| Dividends Paid | -$12M | -$58M | -$58M | -$10M | -$25M |
| Other Financing | -$35M | -$41M | -$78M | -$92M | -$56M |
| Financing Cash Flow | -$47M | -$100M | -$186M | -$134M | -$87M |
| Net Change in Cash | $114M | -$70M | -$46M | $45M | $24M |
| Cash End of Period | $228M | $158M | $111M | $156M | $180M |
| Free Cash Flow | $159M | $26M | $140M | $178M | $116M |